SEC Form 4 · accession 0000891293-15-000067
CTI BIOPHARMA CORP · CTIC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Phillip M Nudelman Ph.D.
Director
Period of report
Dec 10, 2015
Accepted (ET)
Dec 11, 2015 · 6:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000891293
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 10, 2015 | D | 87,481 | $0.00 | D | 254,693 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the forfeiture back to CTIC of shares of restricted stock.